Latest News

  • RESEARCH

    19 Dec 2025

    A New Twist Makes mRNA Drugs More Selective

  • REGULATORY

    18 Dec 2025

    BARDA Pullback Signals New Phase for US mRNA Development

  • INNOVATION

    17 Dec 2025

    mRNA Design Enters a More Predictive Era

  • INVESTMENT

    15 Dec 2025

    Moderna Bets on Debt to Power mRNA’s Next Act

mRNA Finds a New Role in Personalised Cancer Care

Illustration of syringe targeting virus cell, symbolizing mRNA cancer vaccine research

INNOVATION

12 Dec 2025

Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, cost, and broader efficacy

Scientists in a lab using automated tools for AI-driven mRNA research

TECHNOLOGY

10 Dec 2025

AI Sparks a New mRNA Design Race

Raina and Sanofi push AI powered mRNA design, revealing an early gap between predictive and generative tools

BioNTech and CureVac logos displayed with mRNA syringe graphic on blue gradient background

PARTNERSHIPS

9 Dec 2025

Two mRNA Titans Plot a Faster Path to Cancer Breakthroughs

BioNTech-CureVac merger reshapes mRNA development, speeding cancer therapy progress; firms should watch for new partnership and R&D op...

Close-up of mRNA sample tubes with barcodes inside a biomedical lab.

INSIGHTS

8 Dec 2025

The New Contest for Homegrown Drug Power

Moderna expands US mRNA capacity as firms vie for speed, resilience, and onshore strength

Cancer and healthy cell illustration highlighting targets for emerging mRNA cancer therapies

RESEARCH

5 Dec 2025

mRNA Cancer Advance Hints at New Path for In-Body Therapeutics

BNT142 shows early clinical activity as mRNA oncology platforms gain momentum

Person walking toward large federal building with strong morning shadows

REGULATORY

4 Dec 2025

HHS Shift Reshapes Momentum and Strategy Across mRNA Sector

HHS exit from key BARDA vaccine projects forces mRNA players to rethink priorities and chase new paths for growth

Robotic hand interacting with molecular structures symbolizing AI-driven mRNA design.

INNOVATION

3 Dec 2025

AI Tools Edge Into mRNA Design

Early data from platforms like GEMORNA hint at faster mRNA design as drug makers weigh emerging AI approaches

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.